343 related articles for article (PubMed ID: 12911755)
21. Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease.
Kachroo A; Schwarzschild MA
Brain Res; 2014 May; 1563():103-9. PubMed ID: 24680743
[TBL] [Abstract][Full Text] [Related]
22. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
Sconce MD; Churchill MJ; Greene RE; Meshul CK
Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
[TBL] [Abstract][Full Text] [Related]
23. The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat.
Tinakoua A; Bouabid S; Faggiani E; De Deurwaerdère P; Lakhdar-Ghazal N; Benazzouz A
Neuroscience; 2015 Dec; 311():118-29. PubMed ID: 26477982
[TBL] [Abstract][Full Text] [Related]
24. Paraquat and maneb induced neurotoxicity.
Thrash B; Uthayathas S; Karuppagounder SS; Suppiramaniam V; Dhanasekaran M
Proc West Pharmacol Soc; 2007; 50():31-42. PubMed ID: 18605226
[TBL] [Abstract][Full Text] [Related]
25. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
26. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.
Brooks AI; Chadwick CA; Gelbard HA; Cory-Slechta DA; Federoff HJ
Brain Res; 1999 Mar; 823(1-2):1-10. PubMed ID: 10095006
[TBL] [Abstract][Full Text] [Related]
27. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
28. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.
Ares-Santos S; Granado N; Espadas I; Martinez-Murillo R; Moratalla R
Neuropsychopharmacology; 2014 Apr; 39(5):1066-80. PubMed ID: 24169803
[TBL] [Abstract][Full Text] [Related]
29. Paraquat Exposure Increases Oxidative Stress Within the Dorsal Striatum of Male Mice With a Genetic Deficiency in One-carbon Metabolism.
Jadavji NM; Murray LK; Emmerson JT; Rudyk CA; Hayley S; Smith PD
Toxicol Sci; 2019 May; 169(1):25-33. PubMed ID: 30726997
[TBL] [Abstract][Full Text] [Related]
30. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
Ren JP; Zhao YW; Sun XJ
Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
[TBL] [Abstract][Full Text] [Related]
31. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
[TBL] [Abstract][Full Text] [Related]
32. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
33. Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.
Singhal NK; Srivastava G; Patel DK; Jain SK; Singh MP
J Pineal Res; 2011 Mar; 50(2):97-109. PubMed ID: 20964710
[TBL] [Abstract][Full Text] [Related]
34. Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression.
Fernagut PO; Hutson CB; Fleming SM; Tetreaut NA; Salcedo J; Masliah E; Chesselet MF
Synapse; 2007 Dec; 61(12):991-1001. PubMed ID: 17879265
[TBL] [Abstract][Full Text] [Related]
35. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
Kumar A; Leinisch F; Kadiiska MB; Corbett J; Mason RP
Mol Neurobiol; 2016 Jul; 53(5):2983-2994. PubMed ID: 25952542
[TBL] [Abstract][Full Text] [Related]
36. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Wall RA; Jones K
Neurosci Lett; 1986 Sep; 69(3):285-9. PubMed ID: 3489912
[TBL] [Abstract][Full Text] [Related]
37. Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs.
Khwaja M; McCormack A; McIntosh JM; Di Monte DA; Quik M
J Neurochem; 2007 Jan; 100(1):180-90. PubMed ID: 17227438
[TBL] [Abstract][Full Text] [Related]
38. Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.
Kachroo A; Irizarry MC; Schwarzschild MA
Exp Neurol; 2010 Jun; 223(2):657-61. PubMed ID: 20188092
[TBL] [Abstract][Full Text] [Related]
39. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
[TBL] [Abstract][Full Text] [Related]
40. Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson's disease model by inhibiting microglial M1 polarization.
Hou L; Che Y; Sun F; Wang Q
Amino Acids; 2018 May; 50(5):547-556. PubMed ID: 29508060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
